National Drug Code (NDC) Database
Abbey Color Incorporated
-
NDC:
45633-100
-
Nonproprietary Name:
Fluorescein
-
Dosage Form:
POWDER, FOR SOLUTION
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
FLUORESCEIN
-
Start Marketing Date:
1996-01-01
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Abbott Laboratories GmbH
-
NDC:
54809-9048
-
Nonproprietary Name:
Pancrelipase
-
Dosage Form:
CAPSULE, DELAYED RELEASE PELLETS
-
Product Type:
BULK INGREDIENT
-
Strength:
180000; 36000; 114000 [USP'U]/1; [USP'U]/1; [USP'U]/1
-
Substance:
PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE
-
Start Marketing Date:
2013-10-21
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
AbbVie Biotechnology LTD
-
NDC:
76462-0576
-
Nonproprietary Name:
Venetoclax
-
Dosage Form:
TABLET
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
100 mg/1
-
Substance:
VENETOCLAX
-
Start Marketing Date:
2023-03-07
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
AbbVie Deutschland GmbH & Co Kg
-
NDC:
12613-6799
-
Nonproprietary Name:
Lopinavir and Ritonavir
-
Dosage Form:
TABLET, FILM COATED
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
200; 50 mg/1; mg/1
-
Substance:
LOPINAVIR; RITONAVIR
-
Start Marketing Date:
2010-06-18
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
AbbVie Inc.
-
NDC:
0074-9011
-
Nonproprietary Name:
Risankizumab
-
Dosage Form:
LIQUID
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
360 mg/2.4mL
-
Substance:
RISANKIZUMAB
-
Start Marketing Date:
2025-02-04
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
AbbVie Ireland NL B.V.
-
NDC:
68513-9296
-
Nonproprietary Name:
Levothyroxine Sodium
-
Dosage Form:
TABLET
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
112 ug/1
-
Substance:
LEVOTHYROXINE SODIUM
-
Start Marketing Date:
2016-11-18
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
AbbVie SRL
-
NDC:
62526-2325
-
Nonproprietary Name:
Upadacitinib
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
UPADACITINIB
-
Start Marketing Date:
2025-05-28
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Abhilasha Pharma Pvt. Ltd.
-
NDC:
71277-0133
-
Nonproprietary Name:
Ascorbyl Palmitate
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
25 kg/25kg
-
Substance:
ASCORBYL PALMITATE
-
Start Marketing Date:
2018-05-01
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
ABX advanced biochemical compounds Biochemische Forschungsreagenzien GmbH
-
NDC:
71934-0029
-
Nonproprietary Name:
Mannose Triflate, ultra pure
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
80 mg/80mg
-
Substance:
.BETA.-D-MANNOPYRANOSE 1,3,4,6-TETRA-O-ACETATE 2-O-TRIFLUOROMETHANESULFONATE
-
Start Marketing Date:
2001-10-26
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
ABX advanced biochemical compounds Biomedizinische Forschungsreagenzien GmbH
-
NDC:
71934-0035
-
Nonproprietary Name:
18O Water 98 %
-
Dosage Form:
LIQUID
-
Product Type:
BULK INGREDIENT
-
Strength:
50 g/50g
-
Substance:
WATER O-18
-
Start Marketing Date:
2024-08-30
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Create a New Buying Request
Fields marked with * are mandatory.